Status:
WITHDRAWN
CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection
Lead Sponsor:
Stanford University
Conditions:
Brain Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to do a direct comparison of the CONVIVO system (camera imaging device) with our normal Stanford pathology process. CONVIVO system is being tested to see if the device crea...
Detailed Description
Primary Objective: The primary objective of this study is to determine the feasibility of using the CONVIVO imaging system to identify tumor type. Secondary Objective: The secondary objectives are t...
Eligibility Criteria
Inclusion
- The subject demonstrates the ability to understand and the willingness to sign a written informed consent document.
- The subject is suspected to be suffering from following brain tumor: low-grade glioma, high grade-glioma, metastases, or meningioma.
- The subject has been deemed eligible for surgical resection by a practicing Stanford physician.
- Macroscopic tumor visualization using IV infusion of 500mg sodium fluorescein is planned as part of the subject's standard of care treatment.
- The subject is older than 18 years.
- The subject is receiving their surgery at Stanford Hospital.
Exclusion
- \* Patients with any kind of contraindication to the use of fluorescein
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05247749
Start Date
May 1 2021
End Date
May 1 2022
Last Update
February 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.